Publications by authors named "Sandro Perbellini"
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study.
Enzo Bonora Gianni Formentini Francesco Calcaterra Simonetta Lombardi Franco Marini Sandro Perbellini
Diabetes Care
July 2002
Article Synopsis
- This study investigates if HOMA-IR, a measure of insulin resistance, can independently predict cardiovascular disease (CVD) in individuals with type 2 diabetes.
- The analysis involved 1,326 patients and assessed various conventional CVD risk factors alongside HOMA-IR at the start and after an average of 4.5 years.
- Results indicated that higher HOMA-IR values significantly predicted both existing and new cases of CVD, suggesting that improving insulin resistance may help manage cardiovascular risks as well as blood sugar levels in these patients.